Document is current

Any future updates will be listed below

Author’s reply to correspondence on “Expanding the Use of HIPEC in Ovarian Cancer at Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis and Perioperative and Oncologic Outcomes” by Mukurdipi Ray et al.

Crossref DOI link: https://doi.org/10.1245/s10434-024-15503-6

Published Online: 2024-05-30

Published Print: 2024-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark